Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RNTX compared with ACTU: revenue, margins and what each company keeps, and the suppliers and customers both name
RNTX
Rein Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ACTU
Actuate Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
RNTX
Rein Therapeutics, Inc.
vs
ACTU
Actuate Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RNTX, solid
ACTU, dashed
Supply-chain overlap
Revenue flow
RNTX: latest quarter not drawable. ACTU: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RNTX
4
—
Medical University of South Carolina
unlisted
supplier
—
University of Texas at Austin
unlisted
supplier
—
University of Texas Health Science Center at Tyler
unlisted
supplier
—
Vivarta Therapeutics
unlisted
supplier
Shared
0
No disclosed counterparties: ACTU.
Only ACTU
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
RNTX
Rein Therapeutics, Inc.
Change
0.68
▼
−6.41%
· post 0.68
Mkt cap
$57.8M
ACTU
Actuate Therapeutics, Inc.
Change
0.34
▼
−8.98%
· post 0.34
Closed
Oct 30 '26
Mkt cap
$8.0M
vs
Compare
Closed
Oct 30 '26
RNTX
Rein Therapeutics, Inc.
vs
ACTU
Actuate Therapeutics, Inc.
0.68
▼
−6.41%
post 0.68
Price
0.34
▼
−8.98%
post 0.34
$57.8M
Mkt cap
$8.0M
Change
Change
RNTX
0.68
▼
−6.41%
vs
ACTU
0.34
▼
−8.98%
Closed
Oct 30 '26